Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study
about
Rifaximin for the treatment of hepatic encephalopathyRifaximin in the treatment of hepatic encephalopathy.Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence.Rifaximin for the treatment of hepatic encephalopathy.
P2860
Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical effects of rifaximin ...... nt: An open-label, pilot study
@en
Clinical effects of rifaximin ...... t: An open-label, pilot study.
@nl
type
label
Clinical effects of rifaximin ...... nt: An open-label, pilot study
@en
Clinical effects of rifaximin ...... t: An open-label, pilot study.
@nl
prefLabel
Clinical effects of rifaximin ...... nt: An open-label, pilot study
@en
Clinical effects of rifaximin ...... t: An open-label, pilot study.
@nl
P2093
P2860
P1476
Clinical effects of rifaximin ...... nt: An open-label, pilot study
@en
P2093
Claudia Sama
Gabriella Martini
Laura Lambertini
Paolo Pianta
Sonia Berardi
P2860
P304
P356
10.1016/J.CURTHERES.2004.10.002
P577
2004-09-01T00:00:00Z